相似文献
1
Ritalin and serpasil in the treatment of Parkinson's disease.
Dis Nerv Syst. 1956 Nov;17(11):363-4.
2
3
[Comparative therapeutic effect of serpasil-ritalin combination].
Schweiz Med Wochenschr. 1956 Nov 17;86(46):1318-21.
4
Combined ritalin and serpasil therapy in chronic psychoses.
Dis Nerv Syst. 1958 Mar;19(3):122-36.
5
[Observations on neurotic depressions with reference to a combined serpasil-ritalin treatment].
Rass Neuropsichiatr. 1956;10(5-6):198-209.
6
7
[Therapeutic effects of drug antagonists; combined reserpine-ritalin (serpatonil)].
Prensa Med Argent. 1957 Oct 4;44(40):3017-9.
8
Action of methyl-phenidylacetate (ritalin) and reserpine in behavior disorders in children and adults.
Am J Psychiatry. 1958 Oct;115(4):323-8. doi: 10.1176/ajp.115.4.323.
9
[Clinical observations on the association of reserpine with phenyl-piperidyl-2-methyl acetate HCI (ritalin) in arterial hypertension].
G Clin Med. 1956 Jul;37(7):1010-5.
10
The effects of an analeptic (ritalin), an ataraxic (reserpine), and a placebo in senile states.
J Chronic Dis. 1957 Feb;5(2):220-34. doi: 10.1016/0021-9681(57)90137-6.
引用本文的文献
1
Monoamine reuptake inhibitors in Parkinson's disease.
Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.
Zotero 插件